Shionogi

Shionogi

Pharmaceuticals, 300 Campus Dr, Florham Park, New Jersey, 07932, United States, 501-1000 Employees

shionogi.com

  • LinkedIn

phone no Phone Number: 97********

Who is SHIONOGI

About Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages ou...

Read More

map

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SHIONOGI

Shionogi Org Chart and Mapping

VP-Level

Jason Banks

Global VP Clinical Operations

Employees

Michele Nunez

Manager, Ra Submissions

Stacey Baker-Wodarski

Associate Director, Sales and Marketing Operations

BSN Yvette Bruner

Key Account Manager Il, Wi

Kevin Raslowsky

Vice President, Accounting

Donald Pirkl

Director, Third Party Manufacturing

Mark Sveda

Great Lakes Regional Account Manager

Kristen White

Clinical Trial Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Shionogi

Answer: Shionogi's headquarters are located at 300 Campus Dr, Florham Park, New Jersey, 07932, United States

Answer: Shionogi's phone number is 97********

Answer: Shionogi's official website is https://shionogi.com

Answer: Shionogi's revenue is $250 Million to $500 Million

Answer: Shionogi's SIC: 2834

Answer: Shionogi's NAICS: 541715

Answer: Shionogi has 501-1000 employees

Answer: Shionogi is in Pharmaceuticals

Answer: Shionogi contact info: Phone number: 97******** Website: https://shionogi.com

Answer: About Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease. Its Time to Revolutionize Medicine Again More than 23,000 men, women and children in the U.S. die every year from antibiotic-resistant infections while over 4,000 Americans perish from influenza. In addition, over 100 million suffer from chronic pain and 3.9 million adults in the U.S. are diagnosed with liver disease. Shionogis mission is to supply the best possible medicines to protect the health and well-being of the patients we serve. With over 50 years of anti-infective research experience, Shionogi has helped to revolutionize the development of antibacterial and antiviral treatments. As bacteria, pathogens and other viruses adapt to resist existing treatmentscausing millions of untreatable infections around the worldShionogi is pursuing the development of novel treatments to combat this evolving threat. Shionogi, both itself and through innovative alliances, is also pursuing the development of new treatments in other areas of high medical need, including inflammatory pain, neuropathic pain, Alzheimers disease and ADHD. At Shionogi Inc., were intensely focused on developing and commercializing the scientific breakthroughs emerging from our research laboratories in Japan as well as discoveries of our strategic alliance partners. We couple our innovative discovery base with capabilities to advance drug candidates rapidly from lab to clinic to patient, forming, where appropriate, bold new partnerships to accelerate and amplify the availability of these new medications to patients around the world.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access